| Metabolic Syndrome |
1 |
1 |
| Metabolism |
0 |
0.8 |
| Testosterone |
0 |
0.37 |
| Transgender |
0 |
0.31 |
| Social Determinants of Health |
0 |
0.26 |
| Medical Life |
0 |
0.23 |
| Lipids Management |
0 |
0.19 |
| Blood |
0 |
0.18 |
| Body Mass Index |
0 |
0.18 |
| Biliary Disease |
0 |
0.16 |
| Cardiovascular Risk Management |
0 |
0.12 |
| Grant |
0 |
0.12 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.12 |
| Triglycerides |
0 |
0.12 |
| Coronary Artery Disease (CAD) |
0 |
0.09 |
| Fatty Liver |
0 |
0.09 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.09 |
| Hypertension |
0 |
0.09 |
| Liver Disease |
0 |
0.09 |
| California |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Gender Dysphoria |
0 |
0.06 |
| Health Administration |
0 |
0.06 |
| Hormonal Therapy |
0 |
0.06 |
| Insulin Resistance |
0 |
0.06 |
| Lipoproteins |
0 |
0.06 |
| Liver |
0 |
0.06 |
| Match |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Stress |
0 |
0.06 |